UNSW Pharmaceutical Medicine

Who the program is for

The Master of Pharmaceutical Medicine program (program code 9370) is designed for those experienced professionals with advanced knowledge who wish to enter the Therapeutics industry (pharmaceutical, biotechnology or medical technology industries) or those who wish to deepen their understanding of their chosen career path. It provides a deep understanding of the principles of therapeutic product development, regulation and use.
 

How the program is delivered

The program is offered online and will take a minimum of one year full-time equivalent to complete, and most of our students opt to undertake their studies part-time.

The Master of Pharmaceutical Medicine (program code 9370) will be awarded to students who successfully complete the coursework identified below. The program consists of:

  • six core courses
  • two electives 

Within the core courses, there are choices for 3 of the core courses. The elective courses are selected from those that are available in the particular session, provided pre-requisite and timetabling constraints are met.

To fulfil the program requirements students must satisfactorily complete six core courses plus two electives, each worth 6 units of credit, totalling 48 units of credit.

Program Structure

8 courses may be taken from the following core and elective courses (please click on the links to view the Handbook entries):

Core
1. PHAR9101 Introduction to the Therapeutics Industry
2. PHAR9121 Pharmacovigilance
3. PHAR9122 Medical Affairs
4. Regulatory Affairs stream: PHAR9104 Regulatory Affairs OR PHAR9113 International Regulatory Affairs
5. Clinical Trials stream: PHAR9120 Clinical Trials OR PHAR9116 Clinical Trial Management
6. Health Technology Assessment stream: PHAR9114 Health Technology Assessment in Australia OR PHAR9115 Advanced Health Technology Assessment

Electives
1. PHAR9111 Pharmaceutics
2. PHAR9117 Cancer Therapeutics
3. PHAR9118 Therapeutics
4. PHAR9124 Pharmaceutical Medicine Internship

Up to one (1) elective from outside the School of Medical Sciences may be taken in the final year of study as approved by the relevant Program Authorities and Course Convenors.

The program is flexible and allows students to choose related courses to contribute to a particular area of focus, or choose a wider range of courses that reflect diverse interests.

Please note that the Master of Pharmaceutical Medicine does not qualify graduands to practice as a pharmacist in Australia.

Students enrolled in the Master of Pharmaceutical Medicine (program code 9370) may exit early at the Graduate Diploma in Pharmaceutical Medicine (program code 5371; 36 UoC) or the Graduate Certificate in Pharmaceutical Medicine (program code 7370; 24 UoC) if they meet the requirements of these degrees.

Please refer to the 2019 Prospectus, Master of Pharmaceutical Medicine Handbook entry or contact the Pharmaceutical Medicine office (pharm.med@unsw.edu.au) for further information.

November 2018

The Pharmaceutical Medicine team delivered a very successful 1-day Law Masterclass entitled: Therapeutic Good Regulation in Australia: the Challenge of Change

September 2018

Students of Pharmaceutical Medicine program took a trip to the Therapeutic Goods Administration office in Canberra on 13-14 September 2018, where they attended a series of talks and connected with their peers.

June 2018

UNSW Medicine alumna Elizabeth de Somer has been appointed CEO of Medicines Australia.

View the full story here

image - News

November 2017

Dr Chisholm has won the TOPRA Award for Excellence in Regulatory Affairs Education for 2017.

October 2017

Congratulations to Dr Orin Chisholm for her nomination for the award in Excellence in Regulatory Affairs Education from The Organisation for Professionals in Regulatory Affairs (TOPRA).

TOPRA is based in the UK and is an international professional membership organisation for individuals who work in healthcare regulatory affairs. The organisation enables connections and promotes excellence across the healthcare regulatory affairs profession. The winners will be announced at this year’s ceremony which will be held at the Waldorf Hilton in London on 8 November 2017.

September 2017

Very satisfied participants after our 2-day Pharmaceutical Medicine training program for pharmacists from Shandong Province, China.

Students enjoying a tour of the TGA laboratories.

December 2016

Please see the highlights reel from the day below.

 

Best wishes to you all from the Pharmaceutical Medicine team for the holiday period and the new year!

September 2016

Members of the 2016 Pharmaceutical Medicine cohort recently took a trip to the Therapeutic Goods Administration offices in Canberra, where they met members of staff and connected with their peers.

image - News

May 2015

Dr Chisholm and Jan Cooper attended a very successful ARCS Conference at Randwick Racecourse on 5 - 7 May.  

April 2014

Dr Chisholm & Jan Cooper attended the Pharmaceutical Sciences World Congress in Melbourne from 13 – 16 April

iamge - news

June 2013

Dr Chisholm and Jan Cooper had a very successful time at the ARCS Conference in Sydney on 5 and 6 June.

image - News

April 2013

Dr Chisholm hosted a delegation from the Shaanxi Institute for Food and Drug Control, People’s Republic of China, discussing the regulation of medicines in Australia. Another very successful Weekend School was held at the UNSW campus on 13 and 14 April.

March 2013

Dr Chisholm outlined the Pharmaceutical Medicine and Drug Development programs in the recent edition of “The Source”, a publication by ARCS Australia Ltd, the professional development association for individuals involved in the development of therapeutic products.